Proteomics investigation revealed that andrographolide inhibited JAK2/STAT3 signaling by downregulating the phosphorylation status of STAT3, which in turn decreased the expression of tumor PD-L1 in NSCLC [70]. Here, STAT3 is linked to non-small cell lung carcinoma.